• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

急性冠状动脉综合征(ACS)和左束支传导阻滞(LBBB)中的缺血修饰白蛋白(IMA)。它有区别吗?

Ischemia modified albumin (IMA) in acute coronary syndrome (ACS) and left bundle branch block (LBBB). Does it make the difference?

作者信息

Wahab Mohamed Abdel Kader Abdel

机构信息

Department of Cardiology, El Minya University, Egypt.

出版信息

Egypt Heart J. 2017 Sep;69(3):183-190. doi: 10.1016/j.ehj.2017.01.004. Epub 2017 Feb 20.

DOI:10.1016/j.ehj.2017.01.004
PMID:29622975
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5883488/
Abstract

BACKGROUND

Management of patients with a suspected ACS and LBBB is a challenge to the clinician.

AIM

To detect the ability of IMA to exclude myocardial ischemia in suspected patients with ACS and LBBB.

MATERIAL AND METHODS

A total of 68 patients with suspected ACS and LBBB (group I) and another twenty patients age and sex matched known to have LBBB with normal coronary angiography (group II) were included in this study and subjected to: routine laboratory tests, 12 lead ECG, echocardiography, and measurement of serum troponin I (TnI) and IMA (measured by ELISA). Diagnostic coronary angiography was performed on all patients and scored by severity and modified Gensini scores.

RESULTS

IMA and TnI levels are significantly increased in group I compared to group II (P value <0.001. IMA with a cutoff value >95 could predict significant CAD (lesions >50%) with AUC of 0.923, sensitivity of 88%, specificity of 83.33%, PPV of 93.6%, NPV of 71.4% and accuracy 86.76%. Moreover, by using both simple and multiple logistic regression analyses IMA could also independently detect significant CAD. The combined use of IMA and TnI significantly improved the sensitivity and the negative predictive value to 98% and 90.9% respectively.

CONCLUSION

There was a distinct advantage of measuring IMA in patients presenting to the emergency department with acute chest pain and LBBB to rule out a final diagnosis of ACS.

摘要

背景

对疑似急性冠状动脉综合征(ACS)且伴有左束支传导阻滞(LBBB)的患者进行管理,对临床医生来说是一项挑战。

目的

检测缺血修饰白蛋白(IMA)在疑似ACS且伴有LBBB患者中排除心肌缺血的能力。

材料与方法

本研究纳入了68例疑似ACS且伴有LBBB的患者(I组)以及另外20例年龄和性别匹配、已知患有LBBB且冠状动脉造影正常的患者(II组),并对其进行了:常规实验室检查、12导联心电图、超声心动图以及血清肌钙蛋白I(TnI)和IMA(采用酶联免疫吸附测定法检测)的测定。对所有患者进行诊断性冠状动脉造影,并根据严重程度和改良的Gensini评分进行评分。

结果

与II组相比,I组的IMA和TnI水平显著升高(P值<0.001)。IMA临界值>95时可预测显著冠状动脉疾病(病变>50%),曲线下面积(AUC)为0.923,敏感性为88%,特异性为83.33%,阳性预测值为93.6%,阴性预测值为71.4%,准确率为86.76%。此外,通过单因素和多因素逻辑回归分析,IMA也能够独立检测出显著冠状动脉疾病。联合使用IMA和TnI可将敏感性和阴性预测值分别显著提高至98%和90.9%。

结论

对于因急性胸痛和LBBB就诊于急诊科的患者,检测IMA对于排除ACS的最终诊断具有明显优势。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6359/5883488/c3262bbe30b9/gr9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6359/5883488/8570db32cdd4/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6359/5883488/7973b65831f2/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6359/5883488/3ceffb1adfda/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6359/5883488/8e4d2390724d/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6359/5883488/c8a3bf77de98/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6359/5883488/cfb51e9803d7/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6359/5883488/aa4d36c28a4a/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6359/5883488/577902f5cc87/gr8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6359/5883488/c3262bbe30b9/gr9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6359/5883488/8570db32cdd4/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6359/5883488/7973b65831f2/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6359/5883488/3ceffb1adfda/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6359/5883488/8e4d2390724d/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6359/5883488/c8a3bf77de98/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6359/5883488/cfb51e9803d7/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6359/5883488/aa4d36c28a4a/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6359/5883488/577902f5cc87/gr8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6359/5883488/c3262bbe30b9/gr9.jpg

相似文献

1
Ischemia modified albumin (IMA) in acute coronary syndrome (ACS) and left bundle branch block (LBBB). Does it make the difference?急性冠状动脉综合征(ACS)和左束支传导阻滞(LBBB)中的缺血修饰白蛋白(IMA)。它有区别吗?
Egypt Heart J. 2017 Sep;69(3):183-190. doi: 10.1016/j.ehj.2017.01.004. Epub 2017 Feb 20.
2
A Comparative Study of Ischemia-Modified Albumin: A Promising Biomarker for Early Detection of Acute Coronary Syndrome (ACS).缺血修饰白蛋白的比较研究:一种用于急性冠状动脉综合征(ACS)早期检测的有前景的生物标志物。
Cureus. 2023 Aug 30;15(8):e44357. doi: 10.7759/cureus.44357. eCollection 2023 Aug.
3
Ischemia-modified albumin: is it a promising marker in acute coronary syndrome?缺血修饰白蛋白:在急性冠脉综合征中是否是一个有前途的标志物?
BMC Cardiovasc Disord. 2024 Aug 22;24(1):436. doi: 10.1186/s12872-024-04108-2.
4
Ischemia-modified albumin measured with ultra-filtration assay in early diagnosis of acute coronary syndrome.超滤法测定缺血修饰白蛋白在急性冠状动脉综合征早期诊断中的应用。
World J Emerg Med. 2010;1(1):37-40.
5
Ischemia Modified Albumin for the assessment of patients presenting to the emergency department with acute chest pain but normal or non-diagnostic 12-lead electrocardiograms and negative cardiac troponin T.缺血修饰白蛋白用于评估因急性胸痛就诊于急诊科但12导联心电图正常或无诊断意义且心肌肌钙蛋白T阴性的患者。
Int J Cardiol. 2004 Nov;97(2):297-301. doi: 10.1016/j.ijcard.2004.05.042.
6
[Diagnostic value of ischemia-modified albumin in patients with acute coronary syndrome].[缺血修饰白蛋白在急性冠状动脉综合征患者中的诊断价值]
Zhonghua Xin Xue Guan Bing Za Zhi. 2007 Sep;35(9):814-7.
7
Role of "Ischemia Modified Albumin" (IMA) in acute coronary syndromes.“缺血修饰白蛋白”(IMA)在急性冠脉综合征中的作用
Indian Heart J. 2014 Nov-Dec;66(6):656-62. doi: 10.1016/j.ihj.2014.12.005. Epub 2014 Dec 22.
8
Meta-analysis of ischemia-modified albumin to rule out acute coronary syndromes in the emergency department.急诊科应用缺血修饰白蛋白排除急性冠脉综合征的Meta分析
Am Heart J. 2006 Aug;152(2):253-62. doi: 10.1016/j.ahj.2005.12.024.
9
[N-terminal pro-brain natriuretic peptide (NT-proBNP) and ischemia modified albumin (IMA) in exercise induced ischemia in patients with stable coronary artery disease].[N端前脑钠肽(NT-proBNP)和缺血修饰白蛋白(IMA)在稳定型冠状动脉疾病患者运动诱发缺血中的作用]
Pol Arch Med Wewn. 2006 Jul;116(1):640-7.
10
Diagnostic value of ischemia-modified albumin in patients with suspected acute coronary syndrome.缺血修饰白蛋白在疑似急性冠状动脉综合征患者中的诊断价值。
Am J Emerg Med. 2010 Feb;28(2):170-6. doi: 10.1016/j.ajem.2008.10.038.

引用本文的文献

1
From Classic to Modern Prognostic Biomarkers in Patients with Acute Myocardial Infarction.从经典到现代——急性心肌梗死患者的预后生物标志物。
Int J Mol Sci. 2022 Aug 15;23(16):9168. doi: 10.3390/ijms23169168.
2
Novel Invasive and Noninvasive Cardiac-Specific Biomarkers in Obesity and Cardiovascular Diseases.肥胖与心血管疾病的新型侵袭性和非侵袭性心脏特异性生物标志物。
Metab Syndr Relat Disord. 2020 Feb;18(1):10-30. doi: 10.1089/met.2019.0073. Epub 2019 Oct 16.
3
Association between serum lipoprotein-associated phospholipase A2, ischemic modified albumin and acute coronary syndrome: a cross-sectional study.

本文引用的文献

1
Role of "Ischemia Modified Albumin" (IMA) in acute coronary syndromes.“缺血修饰白蛋白”(IMA)在急性冠脉综合征中的作用
Indian Heart J. 2014 Nov-Dec;66(6):656-62. doi: 10.1016/j.ihj.2014.12.005. Epub 2014 Dec 22.
2
Estimation of Ischemia Modified Albumin (IMA) Levels in Patients with Acute Coronary Syndrome.急性冠状动脉综合征患者缺血修饰白蛋白(IMA)水平的评估。
Indian J Clin Biochem. 2014 Jul;29(3):367-71. doi: 10.1007/s12291-013-0367-3. Epub 2013 Aug 10.
3
The clinical assessment of ischaemia modified albumin and troponin I in the early diagnosis of the acute coronary syndrome.
血清脂蛋白相关磷脂酶A2、缺血修饰白蛋白与急性冠状动脉综合征之间的关联:一项横断面研究。
Heart Vessels. 2019 Oct;34(10):1608-1614. doi: 10.1007/s00380-019-01403-3. Epub 2019 Apr 8.
缺血修饰白蛋白和肌钙蛋白I在急性冠脉综合征早期诊断中的临床评估
J Clin Diagn Res. 2013 May;7(5):804-8. doi: 10.7860/JCDR/2013/5288.2944. Epub 2013 May 1.
4
Hospital laboratory reporting may be a barrier to detection of 'microsize' myocardial infarction in the US: an observational study.美国医院实验室报告可能成为检测“微小心肌梗死”的障碍:一项观察性研究。
BMC Health Serv Res. 2013 May 1;13:162. doi: 10.1186/1472-6963-13-162.
5
Ischemia-modified albumin in stable coronary atherosclerotic heart disease: clinical diagnosis and risk stratification.稳定型冠状动脉粥样硬化性心脏病中的缺血修饰白蛋白:临床诊断与风险分层
Coron Artery Dis. 2012 Dec;23(8):538-41. doi: 10.1097/MCA.0b013e328358a5e9.
6
Third universal definition of myocardial infarction.心肌梗死的第三次全球定义。
Eur Heart J. 2012 Oct;33(20):2551-67. doi: 10.1093/eurheartj/ehs184. Epub 2012 Aug 24.
7
Evolving considerations in the management of patients with left bundle branch block and suspected myocardial infarction.左束支传导阻滞伴疑似心肌梗死患者管理中不断变化的考虑因素。
J Am Coll Cardiol. 2012 Jul 10;60(2):96-105. doi: 10.1016/j.jacc.2012.02.054.
8
How to use high-sensitivity cardiac troponins in acute cardiac care.如何在急性心脏护理中使用高敏心肌肌钙蛋白
Eur Heart J. 2012 Sep;33(18):2252-7. doi: 10.1093/eurheartj/ehs154. Epub 2012 Jun 21.
9
Diagnosing acute myocardial infarction in patients with left bundle branch block.诊断左束支传导阻滞患者的急性心肌梗死。
Am J Cardiol. 2011 Sep 15;108(6):782-8. doi: 10.1016/j.amjcard.2011.05.006. Epub 2011 Jul 2.
10
Long-term cardiovascular outcomes in patients with angina pectoris presenting with bundle branch block.伴有束支传导阻滞的心绞痛患者的长期心血管结局。
Am J Cardiol. 2011 Jun 1;107(11):1565-70. doi: 10.1016/j.amjcard.2011.01.039. Epub 2011 Mar 23.